Search research articles
Contact Us
Filters
Showing results (671-680 of 741) with videos related to
Page
of 75
Sort By:
Brain, Behavior, and Immunity
|
February 19, 2019
Plasma estradiol levels and antidepressant effects of omega-3 fatty acids in pregnant women
Daisuke Nishi, Kuan-Pin Su, Kentaro Usuda, et al.
Neuropsychopharmacology Reports
|
February 6, 2020
Plasma levels of matrix metalloproteinase-9 (MMP-9) are associated with cognitive performance in patients with schizophrenia
Noriko Kudo, Hidenaga Yamamori, Tamaki Ishima, et al.
The International Journal of Neuropsychopharmacology
|
March 13, 2018
Plasma Levels of Soluble Tumor Necrosis Factor Receptor 2 (sTNFR2) Are Associated with Hippocampal Volume and Cognitive Performance in Patients with Schizophrenia
Noriko Kudo, Hidenaga Yamamori, Tamaki Ishima, et al.
Psychiatry and Clinical Neurosciences
|
November 29, 2016
Altered serum level of matrix metalloproteinase-9 and its association with decision-making in eating disorders
Junko Matsumoto, Yoshiyuki Hirano, Kenji Hashimoto, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
September 21, 2011
Associations of serum brain-derived neurotrophic factor with cognitive impairments and negative symptoms in schizophrenia
Tomihisa Niitsu, Yukihiko Shirayama, Daisuke Matsuzawa, et al.
Nature Communications
|
July 23, 2025
Small intestinal γδ T17 cells promote SAE through STING/C1q-induced microglial synaptic pruning in male mice
Yuming Wu, Yujing Zhang, Yuan Yu, et al.
Theranostics
|
January 29, 2026
Polydopamine nanoparticles restore cognition via targeted dopamine delivery and septo-hippocampal cholinergic activation
Pan-Miao Liu, Yu-Ge Wang, Ting-Ting Zhu, et al.
Molecular Psychiatry
|
June 7, 2024
Neurocognition and NMDAR co-agonists pathways in individuals with treatment resistant first-episode psychosis: a 3-year follow-up longitudinal study
Sara Camporesi, Lijing Xin, Philippe Golay, et al.
Molecular Psychiatry
|
February 22, 2024
(R)-ketamine restores anterior insular cortex activity and cognitive deficits in social isolation-reared mice
Rei Yokoyama, Yukio Ago, Hisato Igarashi, et al.
Brain, Behavior, and Immunity
|
October 4, 2023
The role of CD38 in inflammation-induced depression-like behavior and the antidepressant effect of (R)-ketamine
Xinying Zhang, Teng He, Zifeng Wu, et al.
Page
of 75
Search research articles
Search
Showing results (671-680 of 741) with videos related to
Sort By:
Page
of 75
Brain, Behavior, and Immunity
|
February 19, 2019
Plasma estradiol levels and antidepressant effects of omega-3 fatty acids in pregnant women
Daisuke Nishi, Kuan-Pin Su, Kentaro Usuda, et al.
Neuropsychopharmacology Reports
|
February 6, 2020
Plasma levels of matrix metalloproteinase-9 (MMP-9) are associated with cognitive performance in patients with schizophrenia
Noriko Kudo, Hidenaga Yamamori, Tamaki Ishima, et al.
The International Journal of Neuropsychopharmacology
|
March 13, 2018
Plasma Levels of Soluble Tumor Necrosis Factor Receptor 2 (sTNFR2) Are Associated with Hippocampal Volume and Cognitive Performance in Patients with Schizophrenia
Noriko Kudo, Hidenaga Yamamori, Tamaki Ishima, et al.
Psychiatry and Clinical Neurosciences
|
November 29, 2016
Altered serum level of matrix metalloproteinase-9 and its association with decision-making in eating disorders
Junko Matsumoto, Yoshiyuki Hirano, Kenji Hashimoto, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
September 21, 2011
Associations of serum brain-derived neurotrophic factor with cognitive impairments and negative symptoms in schizophrenia
Tomihisa Niitsu, Yukihiko Shirayama, Daisuke Matsuzawa, et al.
Nature Communications
|
July 23, 2025
Small intestinal γδ T17 cells promote SAE through STING/C1q-induced microglial synaptic pruning in male mice
Yuming Wu, Yujing Zhang, Yuan Yu, et al.
Theranostics
|
January 29, 2026
Polydopamine nanoparticles restore cognition via targeted dopamine delivery and septo-hippocampal cholinergic activation
Pan-Miao Liu, Yu-Ge Wang, Ting-Ting Zhu, et al.
Molecular Psychiatry
|
June 7, 2024
Neurocognition and NMDAR co-agonists pathways in individuals with treatment resistant first-episode psychosis: a 3-year follow-up longitudinal study
Sara Camporesi, Lijing Xin, Philippe Golay, et al.
Molecular Psychiatry
|
February 22, 2024
(R)-ketamine restores anterior insular cortex activity and cognitive deficits in social isolation-reared mice
Rei Yokoyama, Yukio Ago, Hisato Igarashi, et al.
Brain, Behavior, and Immunity
|
October 4, 2023
The role of CD38 in inflammation-induced depression-like behavior and the antidepressant effect of (R)-ketamine
Xinying Zhang, Teng He, Zifeng Wu, et al.
Page
of 75